Metropolis Healthcare Limited (METROPOLIS) reports strong Q2 FY27 performance with revenue up 16% to ₹497 crore and PAT up 43%.
Nephrocare Health Services Limited reports Q2 FY27 results with revenue up 23.6% YoY and PAT growing 34.7%.
Anthem Biosciences Limited (NSE: ANTHEM) reports strong Q2 & H1 FY27 results with consolidated revenue up 7.2% and EBITDA margins at 50.6%.
Global Health Limited (MEDANTA) reports a 33.6% y-o-y revenue growth and a 38.3% surge in PAT for Q2 FY27.
Max India Limited (MAXIND) reports Q2FY'27 with revenue up 89% YoY, EBITDA loss down 55% YoY, and strong growth in Residences and Care Homes.
Neuland Laboratories Limited (NEULANDLAB) reports Q2 FY27 standalone revenue of ₹457.2 Cr, down 11.4% YoY.
Hikal Limited (HIKAL) announces Q1 FY27 earnings with ₹434 crore revenue, ₹45 crore EBITDA, and ₹(6) crore PAT.
Kopran Limited (KOPRAN) shares Q2 2026-27 financial results, highlighting revenue growth and operational performance.
Yatharth Hospitals reports strong Q2 FY27 results with revenue up 52% YoY and PAT rising 17%, driven by new hospital contributions.
Emcure Pharmaceuticals Limited (EMCURE) reports a 24.3% YoY operating revenue growth and 29.3% PAT growth in Q2FY27.